Hologic Inc
HOLX73.910USD
-0.020-0.03%
Close 10/31, 16:00（ET）Quotes delayed by 15 min
16.42BMarket Cap
29.48P/E TTM
More Details of Hologic Inc Company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Hologic Inc Info
Ticker SymbolHOLX
Company nameHologic Inc
IPO dateMar 01, 1990
CEOMr. Stephen P. (Steve) Macmillan
Number of employees7063
Security typeOrdinary Share
Fiscal year-endMar 01
Address250 Campus Drive
CityMARLBOROUGH
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code01752
Phone15082632900
Websitehttps://www.hologic.com/
Ticker SymbolHOLX
IPO dateMar 01, 1990
CEOMr. Stephen P. (Steve) Macmillan
Company Executives of Hologic Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen P. (Steve) Macmillan
Mr. Stephen P. (Steve) Macmillan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.22M
--
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
47.34K
--
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
18.81K
+11.00%
Ms. Diana De Walt
Ms. Diana De Walt
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.02K
--
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
9.93K
-34.65%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
9.26K
+25.20%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
7.06K
+15.71%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
6.09K
-1.12%
Ms. Nanaz Mohtashami
Ms. Nanaz Mohtashami
Independent Director
Independent Director
4.18K
+80.45%
Ms. Stacey D. Stewart
Ms. Stacey D. Stewart
Independent Director
Independent Director
3.60K
+107.62%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Stephen P. (Steve) Macmillan
Mr. Stephen P. (Steve) Macmillan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.22M
--
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
47.34K
--
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
18.81K
+11.00%
Ms. Diana De Walt
Ms. Diana De Walt
Senior Vice President - Human Resources
Senior Vice President - Human Resources
12.02K
--
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
9.93K
-34.65%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
9.26K
+25.20%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Disposables
658.40M
64.31%
Service
208.80M
20.39%
Capital equipment, components and software
152.00M
14.85%
Other
4.60M
0.45%
By RegionUSD
Name
Revenue
Proportion
United States
760.70M
74.30%
Europe
148.10M
14.47%
Asia
60.30M
5.89%
Rest of World
54.70M
5.34%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Disposables
658.40M
64.31%
Service
208.80M
20.39%
Capital equipment, components and software
152.00M
14.85%
Other
4.60M
0.45%
Shareholding Stats
Updated: Wed, Oct 22
Updated: Wed, Oct 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.00%
T. Rowe Price Investment Management, Inc.
10.82%
BlackRock Institutional Trust Company, N.A.
5.82%
Manulife Investment Management (North America) Limited
4.95%
State Street Investment Management (US)
4.54%
Other
61.87%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.00%
T. Rowe Price Investment Management, Inc.
10.82%
BlackRock Institutional Trust Company, N.A.
5.82%
Manulife Investment Management (North America) Limited
4.95%
State Street Investment Management (US)
4.54%
Other
61.87%
Shareholder Types
Shareholders
Proportion
Investment Advisor
59.24%
Investment Advisor/Hedge Fund
28.04%
Hedge Fund
5.44%
Research Firm
2.46%
Pension Fund
2.45%
Bank and Trust
1.48%
Sovereign Wealth Fund
1.28%
Individual Investor
0.85%
Family Office
0.05%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1586
223.54M
100.44%
-14.31M
2025Q2
1594
230.47M
103.62%
-13.07M
2025Q1
1635
231.71M
103.94%
-14.47M
2024Q4
1617
238.36M
106.18%
-10.05M
2024Q3
1583
240.17M
103.42%
-3.00M
2024Q2
1580
234.77M
100.61%
-6.88M
2024Q1
1595
233.34M
99.37%
-7.61M
2023Q4
1584
235.52M
98.14%
-14.13M
2023Q3
1574
242.15M
98.88%
-13.93M
2023Q2
1583
245.52M
99.77%
-12.39M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
26.70M
12%
-16.89K
-0.06%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
24.08M
10.83%
+6.39M
+36.15%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
12.95M
5.82%
-509.21K
-3.78%
Jun 30, 2025
Manulife Investment Management (North America) Limited
11.02M
4.96%
+8.23M
+294.34%
Jun 30, 2025
State Street Investment Management (US)
10.10M
4.54%
-14.24K
-0.14%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.83M
2.62%
+97.14K
+1.69%
Jun 30, 2025
Victory Capital Management Inc.
5.50M
2.47%
-1.11M
-16.81%
Jun 30, 2025
Invesco Advisers, Inc.
4.33M
1.95%
+3.88M
+868.40%
Jun 30, 2025
Black Creek Investment Management, Inc.
4.03M
1.81%
+832.44K
+26.05%
Jun 30, 2025
Invesco Capital Management LLC
4.01M
1.8%
-361.78K
-8.28%
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
First Trust Nasdaq Lux Digi Health Solutions ETF
4.21%
Otter Creek Focus Strategy ETF
4.02%
John Hancock Fundamental All Cap Core ETF
3.4%
LeaderShares AlphaFactor Tactical Focused ETF
3.23%
First Trust Indxx Medical Devices ETF
2.14%
Formidable ETF
2%
SPDR S&P Health Care Equipment ETF
1.88%
Strategas Global Policy Opportunities ETF
1.8%
Brandes US Small-Mid Cap Value ETF
1.75%
iShares U.S. Medical Devices ETF
1.71%
View more
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion4.21%
Otter Creek Focus Strategy ETF
Proportion4.02%
John Hancock Fundamental All Cap Core ETF
Proportion3.4%
LeaderShares AlphaFactor Tactical Focused ETF
Proportion3.23%
First Trust Indxx Medical Devices ETF
Proportion2.14%
Formidable ETF
Proportion2%
SPDR S&P Health Care Equipment ETF
Proportion1.88%
Strategas Global Policy Opportunities ETF
Proportion1.8%
Brandes US Small-Mid Cap Value ETF
Proportion1.75%
iShares U.S. Medical Devices ETF
Proportion1.71%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
